Compare PRI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRI | BIO |
|---|---|---|
| Founded | 1927 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 6.9B |
| IPO Year | 2009 | N/A |
| Metric | PRI | BIO |
|---|---|---|
| Price | $281.05 | $287.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $294.00 | ★ $339.75 |
| AVG Volume (30 Days) | 165.9K | ★ 430.6K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | ★ 67.10 | N/A |
| EPS | ★ 5.97 | N/A |
| Revenue | ★ $3,291,713,000.00 | N/A |
| Revenue This Year | $3.98 | $2.74 |
| Revenue Next Year | $5.08 | $3.20 |
| P/E Ratio | $46.97 | ★ $9.72 |
| Revenue Growth | ★ 6.56 | N/A |
| 52 Week Low | $230.09 | $211.43 |
| 52 Week High | $288.03 | $343.12 |
| Indicator | PRI | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 61.14 |
| Support Level | $266.27 | $259.31 |
| Resistance Level | $287.39 | $288.48 |
| Average True Range (ATR) | 7.45 | 8.98 |
| MACD | 0.14 | 4.66 |
| Stochastic Oscillator | 68.83 | 93.29 |
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.